Enliven Therapeutics Ratios (2019-2026) | ELVN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Efficiency
Assets Average (Quarter)										77.08M	89.75M	100.34M	87.62M	73.13M	61.88M	71.20M	193.08M	295.68M	281.27M	272.95M	307.32M	334.91M	316.24M	315.60M	314.17M	403.23M	497.38M	483.52M	470.51M
Equity Average (Quarter)										70.28M	82.17M	28.24M	-46.75M	-54.66M	-63.41M	-72.46M	107.30M	285.20M	270.37M	253.83M	281.81M	311.32M	296.67M	299.12M	299.07M	388.38M	482.30M	467.86M	456.48M
Invested Capital (Quarter)										64.97M	99.37M	-42.89M	-50.61M	-58.71M	-68.10M	-76.83M	291.42M	278.99M	261.75M	245.91M	317.71M	304.93M	288.40M	309.85M	288.30M	488.47M	476.12M	459.60M	453.37M
Leverage & Solvency
Equity Ratio (Quarter)										0.90	0.93	-0.46	-0.62	-0.91	-1.15	-0.92	0.96	0.97	0.96	0.90	0.93	0.93	0.94	0.95	0.95	0.97	0.97	0.97	0.98
Valuation
Enterprise Value (Quarter)										-66.77M	-102.84M	-90.28M	-136.29M	-122.36M	-92.97M	-75.54M	-292.10M	-277.87M	-263.48M	-253.15M	-320.50M	-96.92M	-100.67M	-124.17M	-289.56M	-490.50M	-101.73M	-462.62M	-452.40M
Return Ratios
Return on Capital Employed (Quarter)										-67.75%	-58.94%	-55.24%	-61.99%	-65.42%	-71.52%	-63.09%	-25.55%	-20.12%	-26.36%	-33.81%	-32.98%	-31.19%	-33.55%	-34.89%	-36.73%	-29.44%	-23.26%	-4.66%	-3.90%
Return on Invested Capital (Quarter)																							0.00%	0.00%		0.00%
Return on Assets (Quarter)										-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)										-0.01%	-0.01%	-0.02%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%